Pictet Asset Management’s Gilead Sciences GILD Stock Holding History

Pictet Asset Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$357M	Buy	2,574,822 +218,308	+9%	+$30.6M	0.38%	57
2025 Q4	$291M	Sell	2,356,514 -326,886	-12%	-$39.7M	0.28%	83
2025 Q3	$299M	Buy	2,683,400 +46,281	+2%	+$5.26M	0.29%	86
2025 Q2	$292M	Sell	2,637,119 -540,550	-17%	-$57.5M	0.3%	89
2025 Q1	$356M	Sell	3,177,669 -34,985	-1%	-$3.61M	0.4%	60
2024 Q4	$297M	Sell	3,212,654 -1,048,709	-25%	-$94.4M	0.32%	79
2024 Q3	$357M	Buy	4,261,363 +1,679,854	+65%	+$128M	0.39%	61
2024 Q2	$177M	Sell	2,581,509 -1,639,017	-39%	-$109M	0.2%	124
2024 Q1	$309M	Sell	4,220,526 -812,871	-16%	-$62.5M	0.34%	76
2023 Q4	$408M	Sell	5,033,397 -278,672	-5%	-$21.7M	0.45%	49
2023 Q3	$398M	Buy	+5,312,069	New	+$409M	0.49%	45

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Pictet Asset Management's GILD Position: Q1 2026 in Review

Pictet Asset Management increased its Gilead Sciences (GILD) stake by 9.3% in Q1 2026, buying an estimated $30.6M and bringing the position to 2,574,822 shares worth $357M. The position accounts for 0.38% of the portfolio, ranked #57.

Pictet Asset Management first reported a position in GILD in Q3 2023 and has held it in 11 quarters since. The position peaked at $408M in Q4 2023. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

Pictet Asset Management held 2,574,822 shares of Gilead Sciences worth $357M as of Q1 2026.
Pictet Asset Management bought 218,308 Gilead Sciences shares in Q1 2026, an estimated $30.6M.
Gilead Sciences made up 0.38% of Pictet Asset Management's portfolio in Q1 2026, its #57 holding.
Pictet Asset Management first reported a position in Gilead Sciences in Q3 2023 and has held it in 11 quarters since.
Pictet Asset Management's Gilead Sciences position peaked at $408M in Q4 2023.
2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Pictet Asset Management's 13F filing for Q1 2026, filed 22 Apr 2026.